戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1                                              IC50 values for (S)-orteronel were identical for blockin
2                                              IC50 values of the hydrolysates were between 27 and 39mg
3                  VU590 also inhibits Kir7.1 (IC50 approximately 8 muM), and has been used to reveal n
4 mol/L) and IK1 (HEK cells expressing Kir2.1, IC50=44+/-3 mumol/L).
5  32 nM; 3b, IC50 approximately 9 nM; and 14, IC50 approximately 35 nM) inhibit ATX-dependent invasion
6 uctures of the most potent hit (compound 19, IC50 = 2.9 muM) in complex with the enzyme.
7 , risedronate (IC50 > 100 muM) or GGTI-2133 (IC50 > 25 muM) inhibited the growth of ovarian cancer ce
8 xypyridin-3-yl)methyl)-3-phenylisoxazole 25 (IC50 = 2 nM, 14-fold selectivity over CYP11B2), exhibiti
9 he results demonstrated that T. daenensis-3 (IC50=273.36), T. vulgaris (IC50=289.3), and T. fedtschen
10 ulgaris (IC50=289.3), and T. fedtschenkoi-3 (IC50=339.22) possessed higher antioxidant activities tha
11 5-methyl-3-phenylisoxazole-4-carboxamide (3, IC50 = 3 muM), exhibited no activity on the protein kina
12 f 8TQ yielded a small molecule compound (35, IC50 value approximately 400 nM) that is a potent and se
13                                Inhibitor 36 (IC50 = 80 nM) was identified to be highly selective for
14         The three most potent analogues (3a, IC50 approximately 32 nM; 3b, IC50 approximately 9 nM; a
15 analogues (3a, IC50 approximately 32 nM; 3b, IC50 approximately 9 nM; and 14, IC50 approximately 35 n
16 Two of the most potent compounds, 3b and 3f (IC50 approximately 84 nM), lack inhibitory action on ENP
17 ound 21b, a potent inhibitor of Clk1 and -4 (IC50 = 7 and 2.3 nM, respectively), exhibiting an unprec
18 ined plasma levels >/=10 times the hADAMTS-5 IC50 is 5 mg q.d.
19 on needed to suppress palmitate flux by 50% (IC50(palmitate)f).In the omega-3 group, the EPA and DHA
20            The inhibitory concentration 50% (IC50) of NSC319726 was 35-800-fold higher than the Minim
21 t growth, with inhibition concentration 50% (IC50) ranging from 1.6 to 12.0 mg L(-1).
22 beteus nigricolor, potently inhibits NaV1.7 (IC50 0.9 nM) with at least 40-1000-fold selectivity over
23 pyridin-3-yl)methyl)-2-phenylpyridine Ref 7 (IC50= 2 nM) exhibited promutagenic potential as well as
24 s (MBPs) revealed that 8-thioquinoline (8TQ, IC50 value approximately 2.5 muM) displayed strong inhib
25 ivity on L-type calcium channels, i.e. A7r5 (IC50 = 0.18 +/- 0.02 and 0.25 +/- 0.63 mug/ml, respectiv
26 mathematical modelling to enumerate accurate IC50 values for a small library of auxin analogues.
27 had the highest ACE inhibitory activity (ACE IC50=5.21+/-0.94muM).
28 0.14muM which was better than ascorbic acid (IC50=22.59+/-0.30muM).
29 statin (IC50 = 0.6-14 muM), zoledronic acid (IC50 = 21-57 muM), risedronate (IC50 > 100 muM) or GGTI-
30 umol peptide) and ACE inhibitory activities (IC50=44-120muM).
31 sing compounds such as DRI-C21045, activity (IC50) in the low micromolar range has been confirmed in
32  24 displayed excellent inhibitory activity (IC50 of 0.82 +/- 0.18 muM and 1.3 +/- 0.22 muM, respecti
33 anced alpha-glucosidase inhibitory activity (IC50=6.15mug/mL), with castalagin (7) as the main consti
34 and S473, and inhibited Akt kinase activity (IC50 = 6 microM) and downstream signaling.
35  is supported by its agr-quenching activity (IC50 2-32 mug mL(-1)) in transcriptional reporters, dire
36        Compounds 34 and 39 possess activity, IC50 </= 100 nM, in KDM4 family biochemical (RFMS) assay
37                             PSMA affinities (IC50) and internalization kinetics of (99m)Tc-MAS3-y-nal
38 nly 3 of 97 bound A*0101 with high affinity (IC50 < 500 nM).
39  publicly disclosed, submicromolar-affinity (IC50 = 0.2 muM), small-molecule inhibitor of the inward
40 sensitive to PhTX-12 along with alpha3beta4 (IC50 values of 100 nM) with alpha4beta4, alpha4beta2, al
41 ty to low concentrations of 4-aminopyridine (IC50 <100 mum) and block by the peptide inhibitor blood
42 d inhibitory activity against alpha-amylase, IC50 0.74+/-0.02mg/ml and 0.81+/-0.03mg/ml, respectively
43 n the RS4;11 leukemia cell line, achieves an IC50 value of 51 pM in inhibition of RS4;11 cell growth
44 e potent compound with a KD of 50 muM and an IC50 of 18 muM.
45  ne-2-sulfonate (PSB-16133, 61) exhibited an IC50 value of 233 nM, selectivity versus other P2Y recep
46       The most potent compound (ML10) has an IC50 of 160 pM in a PfPKG kinase assay and inhibits P. f
47 ve out of 28 compounds were found to have an IC50 less than 5 muM.
48          Compound 1 turned out to possess an IC50 of 93.7 and of 4.6 nM on MDM2 and MDM4, respectivel
49 ),1-Nal(4),Thr(8)]ghrelin(1-8), possessed an IC50 value of 0.11 nM that is a 28-fold improvement comp
50               Model simulations predicted an IC50 of 1-1.2 mum for SB203580 in hepatocytes.
51                          The array showed an IC50 value of 37.1 +/- 2.4 ng mL(-1) (n = 9), a detectio
52  % of the small molecules prepared showed an IC50 value of less than 100 mum, and approximately 25 %
53                           The assay shows an IC50 of 4.5 +/- 1.2 ng/mL, with a limit of detection of
54                                      With an IC50 in the high picomolar range, the apparent affinity
55 inhibitors of alpha-amylase activity with an IC50 of (0.075+/-0.010-0.103+/-0.017) mg/ml, also a mixe
56 ibition of cell recruitment in vitro with an IC50 of 0.5 nm but demonstrated little efficacy in vario
57 eric modulator of GABArho1 receptors with an IC50 of 1.6 microM, an enhancer of alpha7 nicotinic rece
58         Compound 22a inhibited SphK1 with an IC50 of 2 nM and was more than 100-fold selective for Sp
59 nt at inhibiting chemotaxis in vitro with an IC50 of 21 nm Furthermore, we observed that 1B6 displaye
60  and selective GRK2 inhibitor, 14as, with an IC50 of 30 nM against GRK2 and greater than 230-fold sel
61 synthesized was found to inhibit ACE with an IC50 of 300+/-2microM.
62  and displaced a Tat-derived peptide with an IC50 of 40 muM.
63 740 was also five times more potent, with an IC50 of 5 muM, in a fibroblast-mediated collagen contrac
64 sses expression of gamma2 late genes with an IC50 of 5 mum, which is at least 10 times lower than the
65 ich is a very potent, dual inhibitor with an IC50 of 67 nM for BRPF2 BD, 8 nM for TAF1 BD2, and 106 n
66 minantly by hydroxo-species of U(VI) with an IC50 threshold of approximately 90 muM.
67  a potent inhibitor of alpha-amylase with an IC50 value of 0.046+/-0.004mg/ml.
68 hest inhibition was found to be MCS, with an IC50 value of 0.29muM.
69 the highest ACE inhibitory activity, with an IC50 value of 0.54mg/ml, while the SP hydrolysate exhibi
70   Compound 18 (MM-589) binds to WDR5 with an IC50 value of 0.90 nM (Ki value <1 nM) and inhibits the
71 selective irreversible inhibitor 45a with an IC50 value of 1 nM against the EGFR L858R/T790M double m
72 3K4 methyltransferase (HMT) activity with an IC50 value of 12.7 nM.
73 t than the parent phenyl-diketo acid with an IC50 value of 20 nm.
74 ted DPPH radical scavenging activity with an IC50 value of 20.02+/-0.14muM which was better than asco
75 activity against Leishmania donovani with an IC50 value of 9.22 muM.
76  activity in a dose dependent manner with an IC50 value of about 2mgmL(-1).
77 nhibition of cell proliferation, yielding an IC50 value of 356 +/- 21 nM in neuroblastoma SHSY5Y cell
78                              anthocyanin and IC50 value of 1.60mg/ml for tyrosinase inhibitory activi
79    A validation assay was then conducted and IC50 values were determined.
80 strate and inhibitor enzyme kinetics (Km and IC50), (2) its amino acid sequence and (3) its ability t
81 itory activity with IC50=1.1+/-0.1mug/ml and IC50=19.3+/-1.1mug/ml, respectively.
82 XAV939)(5), i.e., IC50 = 100 pM vs TNKS2 and IC50 = 6.5 muM vs PARP1 for 14.
83 und between total phenolic content (TPC) and IC50 for dark coloured varieties.
84 IC) of 12.5 mug/mL and an Mtb Ag85C apparent IC50 of 8.8 muM.
85 concentration-dependent manner with apparent IC50's equivalent to IC50's on LRRK2-pSer935.
86 he sensitivity of the biosensor, measured as IC50 value, was 1.51U/mL and 0.32U/mL, for anti-TRIM21 a
87 ndeed has a submicromolar potency at ASIC1a (IC50 0.3 muM).
88 y in a mechanistic KDM4C cell imaging assay (IC50 = 6-8 muM).
89 M1 enzymatic activity in biochemical assays (IC50 = 6 nM) with broad selectivity against other histon
90  discovered that d-ShK has a near-background IC50 value approximately 50,000 times lower than that of
91 ual inhibitors of human SHMT1/2 (biochemical IC50 approximately 10 nM).
92 115 hits for which we determined biochemical IC50, thus identifying four chemical series.
93 tion resulted in compound 2 with biochemical IC50 = 160 nM.
94                   The results represented by IC50 values revealed that Huh7 cells had a higher drug r
95 docking scores and experimentally calculated IC50 values.
96 ry safety and high therapeutic indices (CC50/IC50 > 180), and thus representing potential promising l
97 oximately 2000-fold less active toward CDK1 (IC50 86 muM).
98 73) that exhibited high potency toward CDK2 (IC50 0.044 muM) but was approximately 2000-fold less act
99 n selective cytotoxicity against V-C8 cells (IC50 17 microg/ml) compared to V79 cells (IC50 26 microg
100 sistant A2780Cis human ovarian cancer cells (IC50 74 muM, blue light) with a photocytotoxic index <2,
101 in reduced peak SCN5A currents in HEK cells (IC50=110+/-3 mumol/L) and Na(+) current in mouse ventric
102 ntrolled gene transcription in living cells (IC50 = 230 nM), providing the most potent inhibitor of t
103 but they are less cytotoxic on normal cells (IC50 > 100 microM).
104 s (IC50 17 microg/ml) compared to V79 cells (IC50 26 microg/ml).
105 y, led to compound 9b, exhibiting a cellular IC50 for NF-kappaB inhibition of 0.3 muM while retaining
106 kyrase 1 and 2 with biochemical and cellular IC50 values of 29 nM, 6.3 nM and 19 nM, respectively, an
107 HCl] (8) selectively blocked Kv1.1 channels (IC50 approximately 15 muM) recombinantly expressed in ma
108 SY5Y (i.e. both L-type and T-type channels) (IC50 = 8 +/- 0.23 and 10 +/- 0.18 mug/ml, respectively)
109  = 10.6 +/- 1.3 to 1.6 +/- 0.3 muM) and CME (IC50(CME) = 65.9 +/- 7.7 to 3.7 +/- 1.1 mM), which makes
110 ce) showed improved inhibition for collagen (IC50 = 6.7 muM), CRP-XL (IC50 = 53.5 muM), and convulxin
111 han any of its enantiomers S (6c) (collagen, IC50 = 25.3 muM; CRP-XL, IC50 = 181.4 muM; CVX, IC50 = 9
112 uM; CVX, IC50 = 9 muM) and R (6d) (collagen, IC50 = 126.3 muM; CRP-XL, IC50 > 500 muM; CVX, IC50 = 86
113 ion as compared to losartan (LOS) (collagen, IC50 = 10.4 muM; CRP-XL, IC50 = 158 muM; CVX, IC50 = 11
114       Half maximal inhibitory concentration (IC50) of BA were calculated as 13.93microM and 25.66micr
115 PP-IV half maximal inhibitory concentration (IC50) of H4, a potent sample, was maintained following s
116 hibited 50% growth inhibitory concentration (IC50) values that were less than 20 muM in HeLa cells, i
117 mivir half-maximal inhibitory concentration (IC50), and E119D conferred the highest zanamivir IC50.
118 tion [half maximal inhibitory concentration (IC50): 3.8muM] and ATP synthesis (IC50: 0.9muM), and add
119 ains in vitro (50% inhibitory concentration [IC50] > 5 mug/ml).
120 ing potential (50% inhibitory concentration, IC50 approximately 0.59mg/mL) than commercially availabl
121 P-IV half maximal inhibitory concentrations (IC50) of 87.0+/-3.2 and 93.3+/-8.0microM, respectively.
122 001) half-maximal inhibitory concentrations (IC50) than did donor isolates, and their odds of replica
123      Half-maximal inhibitory concentrations (IC50) were obtained for each drug-material combination,
124 olar half-maximal inhibitory concentrations (IC50).
125 o piperaquine 50% inhibitory concentrations (IC50s), and tested whether these genetic variants are ma
126 P-XL (IC50 = 53.5 muM), and convulxin (CVX) (IC50 = 5.7 muM) mediated platelet aggregation as compare
127 C50 = 10.4 muM; CRP-XL, IC50 = 158 muM; CVX, IC50 = 11 muM) than any of its enantiomers S (6c) (colla
128 50 = 126.3 muM; CRP-XL, IC50 > 500 muM; CVX, IC50 = 86.8 muM).
129 0 = 25.3 muM; CRP-XL, IC50 = 181.4 muM; CVX, IC50 = 9 muM) and R (6d) (collagen, IC50 = 126.3 muM; CR
130 thermore, compound 25 inhibited rat CYP11B1 (IC50 = 2 muM) and showed a high oral bioavailability (F
131       All BODIPYs were nontoxic in the dark (IC50 > 200 muM) and showed low phototoxicity (IC50 > 100
132  of TRAP5a and 5b activity reported to date (IC50 1.3 and 1.8 muM respectively).
133 h significantly associated with daunorubicin IC50 values in a panel of lymphoblastoid cell lines.
134 , IL-8, and MIP-1beta) by monocytes and DCs (IC50 < 1 muM) and prevented DC maturation upon TLR4 acti
135  most active being benzothiazole derivative (IC50 = 0.56 muM).
136  For assay validation, we finally determined IC50 values for three unlabeled peptides, that is: (i) l
137 , outperforming the standard drug donepezil (IC50 = 11 nM), most of the corresponding 1,4-dihydropyri
138  as least sensitive because they showed drug IC50 value greater than the cell panel median and lacked
139 he "standard" inhibitor 1 (XAV939)(5), i.e., IC50 = 100 pM vs TNKS2 and IC50 = 6.5 muM vs PARP1 for 1
140 onstrated a strong radical quenching effect (IC50: 0.48mg/ml).
141 V from black soybean was the most effective (IC50: 0.25mg/mL) against alpha-amylase; Fraction V from
142 nd delphinidin-3-O-glucoside inhibited EGFR (IC50=0.10 and 2.37microM, respectively).
143 , this compound was still not potent enough (IC50 approximately 53 nM) to enter preclinical studies.
144 d dehydrogenase type 1 (11beta-HSD1) enzyme (IC50 3.0 nM) with >10000-fold selectivity over human 11b
145 ion from T4, respectively, with an estimated IC50 of 160 nM; no statistically significant inhibition
146  legal driving limit of 0.08% (w/v) ethanol (IC50 = 0.2% v/v, 34 mM).
147          The concentration inhibition fifty (IC50) for BL, SH, RG on HT-29 and HCT-116 cell prolifera
148               These compounds exhibited GSK3 IC50s in the low nanomolar range and excellent selectivi
149  be highly potent dual binding site hAChEIs (IC50 up to 3 nM), outperforming the standard drug donepe
150 ess than 100 mum, and approximately 25 % had IC50 values below 1 mum to Mcl-1.
151 roacetamide at the thiophene 2-position, had IC50 of approximately 30 nM, approximately 3.6-fold more
152 al sodium channel from Bacillus halodurans) (IC50 = 112 nM and 30 nM, respectively).
153 phoramidate prodrugs of these compounds have IC50 values in the low micromolar range in Pf lines and
154 d 7G8) P. falciparum strains with 5/6 having IC50 < 100 nM against the NF54 strain.
155                         LRRK2-pSer935 HEK293 IC50 data for 22 were consistent with binding to Ala2016
156 representing IKr (CHO cells expressing hERG; IC50=219+/-21 mumol/L) and IKs (CHO cells expressing KCN
157 he growth of HCC cells, although at a higher IC50 as compared with breast cancer cells, likely due to
158 ve submicromolar inhibitor of BuChE (huBuChE IC50 = 0.443 muM) with high permeability in the PAMPA-BB
159 IDPR inhibit CD38-mediated cADPR hydrolysis (IC50 7 muM and 21 microM respectively) with 8-Br-L-cIDPR
160 icromolar inhibition against both dynamin I (IC50 = 10.6 +/- 1.3 to 1.6 +/- 0.3 muM) and CME (IC50(CM
161 otency of ATRA on HCC cell growth, improving IC50 by over 3-fold.
162 pounds displayed a similar decrease (30%) in IC50 for inhibition of [(3)H]DA uptake by cocaine in WT
163 rug-material combination, and an increase in IC50 of approximately 4.3x was observed in PDMS devices
164    ToF-SIMS data showed the bias observed in IC50 values found in PDMS devices was directly related t
165 e retaining a potent EGFR kinase inhibition (IC50 = 60 nM).
166 20%), ROS (32%) and lipoxygenase inhibition (IC50=31.24muM) compared to FS.
167  hits into potent small molecule inhibitors (IC50 < 300 nM).
168                  The most potent inhibitors (IC50 </= 50 nM) significantly decreased viability, clono
169 e IC50 = 76 nM, and MDR Mtb patient isolates IC50 = 140 nM) and favorable pharmacokinetic and toxicol
170 e and a plasma concentration higher than its IC50 for over 7 h.
171 ted gastrointestinal digestion (SGID, DPP-IV IC50=0.60+/-0.06vs.
172 ty was found with the amino acid Tyr (DPP-IV IC50=75.15+/-0.84muM).
173 ) and IKs (CHO cells expressing KCNQ1+KCNE1; IC50=184+/-12 mumol/L), whereas azithromycin suppressed
174 alpha-amylase, alpha-glucosidase and lipase (IC50: 0.38mg/mL, 0.87mug/mL and 15mug/mL, respectively).
175 and esophageal cancer cells and showed lower IC50 values than curcumin.
176 ibitors in that they demonstrated the lowest IC50 values (2 muM) ever observed among all indole-based
177  inhibition zone diameter, the half maximal (IC50) and the minimal (MIC) inhibitory concentrations.
178  falciparum laboratory-adapted strains (mean IC50 32 nM), Ugandan field isolates (mean ex vivo IC50 6
179 lade isolates (n = 117) with a potent median IC50 of 0.028 mug ml(-1).
180  Axl receptor activation with low micromolar IC50s in cell-based reporter assays, inhibit Gas6-induci
181 promising scaffold with very low micromolar (IC50 approximately 1 muM) NNMT inhibition.
182 fractions of CO7 cultivar of foxtail millet (IC50, 22.37 and 57.26microg/ml) and CO4 cultivar of litt
183 icrog/ml) and CO4 cultivar of little millet (IC50, 18.97 and 55.69microg/ml) displayed strong inhibit
184 ys acceptable antituberculosis activity (Mtb IC50 = 525 nM, Mtb Wayne IC50 = 76 nM, and MDR Mtb patie
185 a(++) currents (rabbit ventricular myocytes, IC50=66.5+/-4 mumol/L) and IK1 (HEK cells expressing Kir
186 46, 49, and 50 showed single-digit nanomolar IC50 values for in vitro inhibition of KDM1A, with high
187 s a result, compound 12 showed low nanomolar IC50 for both targets.
188 most interesting compound 9 showed nanomolar IC50 values for both proteins, membrane permeability, an
189 h affinity ligands for the ER with nanomolar IC50 binding values.
190 igh in vitro activity against C. neoformans (IC50 = 0.35 mug/mL, MIC = MFC = 0.63 mug/mL) with a sele
191                         1g-i revealed low nM IC50 values for HDAC6 with up to 15-fold preference over
192 f nitrate with strong pi affinity nullified (IC50 = 2.2 mM) the responsiveness of anion-pi catalysts
193 ,3'-T2 formation from rT3 was also observed (IC50 approximately 100 nM).
194 s ranged from 52.5 to 67.2mug/mL in terms of IC50 values following fermentation, while the alpha-gluc
195     Compounds 11 and 12 showed the values of IC50 at 11.9 and 17.2 muM against neglected Chagas' dise
196 606120 is a selective antagonist for P2X7Rs (IC50 of 10 nM) and ineffective at the P2X1R (at 10 muM)
197                                   Paclitaxel IC50 in PC3 and PC3-TXR cells was 55.6 and 2,580 nmol/L,
198 d resistant Plasmodium falciparum parasites (IC50 1-5 nM) as well as against gametocytes.
199 nst Plasmodium falciparum malaria parasites (IC50 approximately 1 muM).
200 tivity (10-14mumol Trolox eq./mumol peptide; IC50=11-21muM).
201 due to accumulation of hydrophobic peptides (IC50 between 12 and 21mg/l).
202 rate model to predict resistance phenotypes (IC50) quantitatively from a unique combination of the in
203 els exhibited more potent photocytotoxicity (IC50 3 muM, blue light) with a photocytotoxic index >5.
204 C50 > 200 muM) and showed low phototoxicity (IC50 > 100 muM, 1.5 J/cm(2)) toward human HEp2 cells.
205 me 14 also associate with raised piperaquine IC50s.
206 gion that associates with raised piperaquine IC50s.
207                                Pitavastatin (IC50 = 0.6-14 muM), zoledronic acid (IC50 = 21-57 muM),
208 nd imazalil (enilconazole)-showed potencies (IC50) in the range between 175 and 1,500 nM, similar to
209                            The high potency (IC50 of 31 nM [MMP-10] and 5 nM [MMP-13]) and selectivit
210                           The highly potent (IC50 = 10 nM) inhibitor N-(3,4-dimethoxyphenyl)ethyl ami
211  from black turtle bean was the most potent (IC50: 0.25mug/mL) against alpha-glucosidase; Fraction IV
212 5-lipoxygenase (5-LOX) inhibition potential (IC50 0.76-0.92mg/mL) of the polyketides in consonant wit
213 rom black turtle bean was the most powerful (IC50: 76mug/mL) against lipase.
214 n wild-type RTD-1 in inhibiting LF protease (IC50 = 43 +/- 3 nM, Ki = 18 +/- 1 nM).
215 itor of anthrax lethal factor (LF) protease (IC50 = 390 +/- 20 nM, Ki = 365 +/- 20 nM) and a weak inh
216 agement was demonstrated, with LRRK2-pSer935 IC50 values for 22 in mouse brain and kidney being 1.3 a
217 inhibits the JNK3 in the subnanomolar range (IC50 = 0.3 nM), shows high metabolic stability in human
218 e 22.4-40.6muM) and myeloperoxidase release (IC50 in the range 22.2-32.2muM) from stimulated human ne
219 s as potent blockers of TGF-beta1 responses (IC50 50 nM), Snail1 expression, and collagen deposition
220 ther characterization of ciproxifan revealed IC50 values in a micromolar concentration range for huma
221 dronic acid (IC50 = 21-57 muM), risedronate (IC50 > 100 muM) or GGTI-2133 (IC50 > 25 muM) inhibited t
222 ith excellent recovery and high sensitivity, IC50 = 0.28 mug/L, with a limit of detection that is wel
223 ere considerably weaker inhibitors of SGLT1 (IC50 = 10-19 muM).
224         The most potent inhibitors of SGLT2 (IC50 = 9-23 nM) were considerably weaker inhibitors of S
225  The three most potent compounds 1g-i showed IC50 values in the low muM and sub-muM range.
226                                   Similarly, IC50 values for 26 structurally diverse compounds reveal
227 ound displays nanomolar in vitro and in situ IC50 values and fully inhibits ABHD3 activity in human c
228      Exposure of HeLa cells to Cu(PyBD).SO4 (IC50 = 10 muM) results in a G2/M arrest compared with un
229 ane permeabilized), BeauIII inhibited SOAT1 (IC50, 1.8 microM) and SOAT2 (5.9 microM).
230 lized), BeauIII selectively inhibited SOAT1 (IC50; 5.0 microM (SOAT1) vs >90 microM (SOAT2)), while i
231 t the production of reactive oxygen species (IC50 in the range 22.4-40.6muM) and myeloperoxidase rele
232 ch inhibited the enzyme with a submicromolar IC50 (0.162 muM), capable of inhibiting the target in ce
233 entration (IC50): 3.8muM] and ATP synthesis (IC50: 0.9muM), and additional findings supported inhibit
234                  Compound 1 displayed a TarO IC50 of 125 nM in an enzyme assay and possessed very hig
235                                          The IC50 (i.e., concentration resulting in 50% current decre
236                                          The IC50 value equal to 70mM was very high compared to usual
237                                          The IC50 values for ACE inhibition by OD-FPH and FD-FPH samp
238                                          The IC50 values for compounds 1-3 are within nanomolar range
239                                          The IC50 values for rimantadine were low across all genotype
240                                          The IC50 values of p7-1a and p7-4a were 0.7 +/- 0.1 nM and 3
241  more potent than its congener GL331 and the IC50 values are from 0.34 +/- 0.21 to 3.54 +/- 0.54 micr
242 ure for envisioned clinical application, the IC50 of MEAN was not significantly changed in several dr
243 lowing knockdown of MARCKS in RCC cells, the IC50 of the multikinase inhibitor regorafenib was reduce
244                             Importantly, the IC50 for NSAH is within twofold of gemcitabine for growt
245  Under hypoxic conditions, a decrease in the IC50 of MTX and MTX-loaded MSNR was observed when compar
246 up, there were no significant changes in the IC50(palmitate)f (19 +/- 2 compared with 24 +/- 3 muIU/m
247 g so, we reveal how classic metrics like the IC50 and minimal inhibitory concentration (MIC) are dubi
248                We show that estimates of the IC50 (employing a novel specific and efficient assay tha
249 s reduced cell proliferation and reduced the IC50 inhibitory concentration of chemotherapeutic drugs
250  leukemic cytokine secretion and reduced the IC50 of chemotherapeutic drug treatments in AML cells.
251 m, which is at least 10 times lower than the IC50 value required for inhibition of expression of earl
252 of PARP inhibitor >1000-fold higher than the IC50 were required to ablate both ADP-ribosylation and X
253                                    Also, the IC50s for RU.365, RU.332 and RU.521 within panel h were
254  the rationale behind the disparity in their IC50.
255 nt manner with apparent IC50's equivalent to IC50's on LRRK2-pSer935.
256 han commercially available alpha-tocopherol (IC50 0.63mg/mL).
257 potent than cocaine at inhibiting DA uptake (IC50 = 107 nM).
258 t potent compound, has an excellent in vitro IC50 (0.056 nM) and improved aqueous solubility as well
259                                     In vitro IC50 values were 11-48 ng/mL in HER2 3+ SK-BR-3 and KPL-
260 t disrupt the EthR-DNA interaction in vitro (IC50 =460-610 mum) and bind to the hydrophobic channel o
261 32 nM), Ugandan field isolates (mean ex vivo IC50 64 nM), and murine P. berghei and P. falciparum inf
262 t T. daenensis-3 (IC50=273.36), T. vulgaris (IC50=289.3), and T. fedtschenkoi-3 (IC50=339.22) possess
263 losis activity (Mtb IC50 = 525 nM, Mtb Wayne IC50 = 76 nM, and MDR Mtb patient isolates IC50 = 140 nM
264 tumors, is a bona fide PORCN inhibitor whose IC50 for inhibition of Wnt fatty acylation in vitro clos
265 ibits JAK1 and HDACs 1, 2, 3, 6, and 10 with IC50 values of less than 20 nM, is <100 nM potent agains
266 yl)-5-fluoro-1H-benzo [d]imidazole (42) with IC50 values of 44 and 50 nM, respectively.
267 owed the best ACE-inhibitory activities with IC50 values of 53.31 and 75.05microg/ml, respectively.
268 tency (inhibiting PARP1 enzyme activity with IC50 = 0.079 muM), as well as inhibiting PARP-modulated
269 , 1b displayed full antagonist activity with IC50 = 6 +/- 2 muM.
270 hibit an outstanding antiviral activity with IC50 in the sub-nanomolar range!
271 nd strongly inhibit telomerase activity with IC50 of 600 nM.
272 e and alpha-amylase inhibitory activity with IC50=1.1+/-0.1mug/ml and IC50=19.3+/-1.1mug/ml, respecti
273 he greatest antiproliferative activity, with IC50 values of 0.35-4.6 nM (4g) and 0.5-20.2 nM (4i), wh
274 erial and human salivary alpha-amylases with IC50 values of 0.11 and 0.04mumol, respectively, whereas
275 lenging triple mutant L858R/T790M/C797S with IC50 values in the low nanomolar range.
276  activity against MCF-7 and HL-60 cells with IC50 of 6.13 +/- 0.64 and 4.43 +/- 0.35, respectively.
277 liferative effects against cancer cells with IC50 range of 4.43 +/- 0.35 to 49.63 +/- 3.59 microM, bu
278 l extraction methods (10.93mg/g content with IC50 of 2.81mg/ml).
279  histamine release were dose dependent, with IC50 values ranging between 0.001 and 0.5 mumol/L, and t
280  potent compound is the 4-F derivative, with IC50 in the 10(-8) M range and selectivities around 1000
281  activity against Plasmodium falciparum with IC50 values of 1.84, 8.36, and 6.95 muM, respectively.
282 2C notably inhibited alpha-glucosidase, with IC50=9.89 and 8.05mug/mL, respectively.
283 well as significant inhibition of HDAC6 with IC50 values in the submicromolar concentration range.
284 entified as jack bean urease inhibitors with IC50 values of 2.8 and 5.0mM, respectively.
285 ds 1 and 3 strongly inhibited NF-kappaB with IC50 values of 7.1 and 1.5 muM, respectively.
286 accumulation in small intestinal loops, with IC50 down to 0.1 mg/kg.
287           Five fragments inhibited MTH1 with IC50 values ranging from 6 to 79 muM.
288 y to inhibit the growth of the parasite with IC50 values in submicromolar range.
289 -3-gallate, and theaflavin inhibited PL with IC50 of 1.9, 4.2, 3.0, and >10mumol/L.
290 A topoisomerase I inhibition properties with IC50 values <5.0 muM.
291 native membranes or in proteoliposomes, with IC50 values in the 10-40 nm range.
292 had 50- to 1000-fold lower sensitivity, with IC50 values of 2402 +/- 334 nM and 344 +/- 64 nM, respec
293 BP1 and SMB methylation and cell stasis with IC50 values in the nanomolar range.
294 ble enterotoxin of E. coli (STa toxin), with IC50 down to approximately 5 nM.
295 hich inhibited IMPalpha/beta1:C binding with IC50s as low as 5 microM.
296 ition for collagen (IC50 = 6.7 muM), CRP-XL (IC50 = 53.5 muM), and convulxin (CVX) (IC50 = 5.7 muM) m
297  R (6d) (collagen, IC50 = 126.3 muM; CRP-XL, IC50 > 500 muM; CVX, IC50 = 86.8 muM).
298 an (LOS) (collagen, IC50 = 10.4 muM; CRP-XL, IC50 = 158 muM; CVX, IC50 = 11 muM) than any of its enan
299 s S (6c) (collagen, IC50 = 25.3 muM; CRP-XL, IC50 = 181.4 muM; CVX, IC50 = 9 muM) and R (6d) (collage
300 ), and E119D conferred the highest zanamivir IC50.

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top